Truist Lowers PT on UnitedHealth (UNH) to $345 From $360, Keeps a Buy Rating

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best long term low volatility stocks to buy now. On July 16, Truist lowered the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) to $345 from $360 while keeping a Buy rating on the shares.

UnitedHealth Group Incorporated (UNH): "Medicare Fraud Is Prison," Warns Jim Cramer

A senior healthcare professional giving advice to a patient in a clinic.

The rating update came as part of a broader research note previewing the fiscal Q2 2025 results for the Healthcare Services sector. The firm told investors in a research note that the quarter is expected to exhibit an ongoing mixed, sector-dependent backdrop across its coverage universe, focusing on selectivity and utilization-leveraged names that are best positioned.

Truist acknowledged that Managed Care is continuing to face challenges, but it is remaining bullish on the core demand drivers for the industry. The firm also stated that it sees the Reconciliation Bill as having provided heightened clarity around the regulatory framework.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations.

While we acknowledge the potential of UNH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.